Ng concentration also differentiates early AD patients from controls with diagnostic utility comparable to core AD CSF biomarkers,70, 71 and increases over time in cognitively unimpaired but not MCI or AD patients suggesting that Ng is tracking with synaptic dysfunction or loss during pre‐symptomatic stages.69 This evidence concerns the gene NRGN and Alzheimer disease.